Sygnus Biotech Logo
SBFLOX-OR
Rx Only
Ready for 24-48h Central Dispatch
In Stock

SBFLOX-OR Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download
SyrupPrescription Required (Schedule Drug)

SBFLOX-OR

5.0(1 review)
Verified Quality Batch
Active Drug Composition

Ofloxacin 50mg + Ornidazole 125mg + Racecadotril 15mg

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

SBFLOX-OR is a broad-spectrum bactericidal antimicrobial agent exhibiting enhanced pharmacokinetic tissue penetration against susceptible gram-positive and gram-negative pathogens.

Dosage FormOral Suspension
Packaging Presentation30ml
B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Lower Respiratory Tract Infections
Acute Bacterial Sinusitis
Urinary Tract Infections (UTI)
Skin and Soft Tissue Infections
Community-Acquired Pneumonia

Mechanism of Action (MOA)

Inhibits bacterial DNA gyrase (type II topoisomerase) and topoisomerase IV enzymes required for bacterial DNA replication, transcription, and repair.

Dosage & Posology

Adult: One dose once or twice daily depending on infectious severity. Complete full course to prevent antimicrobial resistance.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store below 25°C. Do not freeze. Keep container tightly closed.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentSyrup
Dosage FormOral Suspension
Packaging Type30ml
Regulatory ScheduleSchedule H
Country of OriginIndia
Quality StandardWHO-GMP & ISO 9001:2015
Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

SBFLOX-OR features Ofloxacin 50mg + Ornidazole 125mg + Racecadotril 15mg prepared to high pharmaceutical purity standards.

Therapeutic ClassificationSyrup
Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Verified Practitioner & Distributor Feedback

Customer & Clinical Reviews

Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.

5.0

Based on 1 verified review

5
1 (100%)
4
0 (0%)
3
0 (0%)
2
0 (0%)
1
0 (0%)
Verified Feedback
3 Aug 2026

Tracked for therapeutic compliance for SBFLOX-OR

SBFLOX-OR has been tracked for therapeutic compliance across diverse adult cohorts, with attending physicians reporting swift symptom reduction across outpatients. The secondary carton board quality is heavy and durable, protecting contents from transport shock. Zero supply interruptions and consistent batch quality make this a standout pharmaceutical line.

Dr. Alok Verma•Cardiology Consultant (MD, DM), Lucknow
Distributor Inquiries

Questions Regarding SBFLOX-OR

What is the therapeutic indication and composition of SBFLOX-OR?

SBFLOX-OR contains Ofloxacin 50mg + Ornidazole 125mg + Racecadotril 15mg indicated for Lower Respiratory Tract Infections as formulated by Sygnus Biotech.

What packaging presentations are available for SBFLOX-OR?

SBFLOX-OR is supplied in tamper-evident 100ml / 200ml PET Bottle with Graduated Measuring Cap, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for SBFLOX-OR?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SBFLOX-OR along with promotional visual aids, product cards, and marketing support.

What is the regulatory schedule and minimum order quantity (MOQ)?

SBFLOX-OR is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.

Related Formulations in Syrup

View all Syrup →
Syrup
S-KRAL

S-KRAL

Oxetacaine 20mg + Sucralfate 1gm

Pack:100ml
Syrup
SB CAIN GEL

SB CAIN GEL

Oxetacaine 10mg + Aluminium Hydroxide 0.291gm

Pack:200ml
Syrup
TRYLAX

TRYLAX

Liquid Paraffin 1.25ml + Milk of Magnesia 3.75ml + Sodium Picosulphate 3.33mg

Pack:170ml
Syrup
SYPROVIT

SYPROVIT

Cyproheptadine HCl 2mg + Tricholine Citrate 0.275mg

Pack:200ml
Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of SBFLOX-OR

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.